All CLSI products contain natural substances abundant in medicinal plants that have been scientifically proven to protect cells that are important for certain body functions from harmful agents that cause the onset of unwanted aging-associated diseases.

All CLSI products are manufactured using Global Life Laboratory Corporation’s unique proprietary technologies under a strict Food and Drug Administration (FDA)’s current Good Manufacturing Practice (cGMP) guideline, and the natural substances therein are patent protected. The medicinal plants and the biologically active natural substances present therein that constitute CLSI products have been intensely investigated by scientists over several decades to prove their safety and bioefficacy. All CLSI products are manufactured in the USA according to the guidelines set forth by the Food and Drug Administration (FDA). Due to the nature and properties of complementary and alternative medicine and the definitions thereof established by FDA, all CLSI products are manufactured according to the strict guideline established by FDA’s “Dietary Supplement Health and Education Act (DSHEA) (Pub. L. 103-417) signed into law on October 25, 1994.”

In October 1994, the Dietary Supplement Health and Education Act (DSHEA) was signed into law by President Clinton. Before this time, dietary supplements were subject to the same regulatory requirements as were other foods. This new law, which amended the Federal Food, Drug, and Cosmetic Act, created a new regulatory framework for the safety and labeling of dietary supplements. (Note**: For additional information, please consult FDA’s ruling on complementary and alternative medicine and dietary supplements.)

Core LifeSource, Inc. (CLSI) is a nutra-pharmaceutical company that focuses on manufacturing, distributing, and marketing products designed to improve the health and the lifestyle of aging man and woman alike through means of complementary and alternative medicine.

CLSI was founded on an understanding that everyone will need to deal with and overcome debilitating aging-associated diseases. CLSI is striving to be a healthcare leader for aging population by providing methods and means to overcome debilitating aging-associated diseases.

The current trend in the development of medical technologies and understanding of diseases and treatment has been causing the rise of expected lifespan of human to an unexpectedly profound level, resulting in a large increase of aging population. However, aging-associated diseases continue to plague us, and the battle against these diseases is far from being under control. Some examples of such disease are Alzheimer’s disease, diabetes, and osteoporosis. Thus these aging-associated diseases become major economic and health concerns in the new millennium.